TW200610763A - Quaternary alkaloid derivatives - Google Patents
Quaternary alkaloid derivativesInfo
- Publication number
- TW200610763A TW200610763A TW094132316A TW94132316A TW200610763A TW 200610763 A TW200610763 A TW 200610763A TW 094132316 A TW094132316 A TW 094132316A TW 94132316 A TW94132316 A TW 94132316A TW 200610763 A TW200610763 A TW 200610763A
- Authority
- TW
- Taiwan
- Prior art keywords
- reaction products
- water
- treatment
- reaction mixture
- derivatizing agent
- Prior art date
Links
- 150000003797 alkaloid derivatives Chemical group 0.000 title abstract 3
- 239000007795 chemical reaction product Substances 0.000 abstract 3
- 229930013930 alkaloid Natural products 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000011541 reaction mixture Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- FOCVUCIESVLUNU-UHFFFAOYSA-N Thiotepa Chemical compound C1CN1P(N1CC1)(=S)N1CC1 FOCVUCIESVLUNU-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000003125 aqueous solvent Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000036737 immune function Effects 0.000 abstract 1
- 230000003818 metabolic dysfunction Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960001196 thiotepa Drugs 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/568—Four-membered rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to alkaloid reaction products obtainable in a process wherein alkaloids are reacted with a derivatizing agent, preferably thiotepa or another one of the compounds listed in Fig.3, whereafter unreacted derivatizing agent and other water-soluble compounds are removed from the reaction mixture by washing with water or a suitable aqueous solvent, whereafter the reaction mixture is subjected to a treatment with strong acid, preferably hydrogen chloride (HCl), to precipitate a water soluble salt of the reaction products. The precipitated reaction products comprise at least one quaternary alkaloid derivative and are suitable as drugs for prophylactic or therapeutic application, particularly in the treatment of immunological or metabolic dysfunctions, and cancer.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04022299 | 2004-09-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200610763A true TW200610763A (en) | 2006-04-01 |
Family
ID=35501129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094132316A TW200610763A (en) | 2004-09-20 | 2005-09-19 | Quaternary alkaloid derivatives |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1833839A1 (en) |
| AR (1) | AR050648A1 (en) |
| CA (1) | CA2593202A1 (en) |
| TW (1) | TW200610763A (en) |
| WO (1) | WO2006032380A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20131495A1 (en) | 2013-09-10 | 2015-03-11 | Ce R C Ar Di Paolo Maestri | USEFUL COMPOSITIONS FOR CHEMOTHERAPY-RESISTANT CANCER TREATMENT |
| CN112023053A (en) | 2014-07-17 | 2020-12-04 | 益生菌股份公司 | Composition for treating tumors resistant to chemotherapy and application thereof |
| WO2016139625A1 (en) | 2015-03-05 | 2016-09-09 | Probiotical S.P.A. | Compositions for use in the treatment of tumors resistant to chemotherapy |
| US20240139162A1 (en) * | 2019-10-17 | 2024-05-02 | Chengdu Anticancer Bioscience, Ltd. | Benzophenanthridine Alkaloids and Their Methods of Use |
| CN113549085B (en) * | 2021-07-16 | 2022-11-22 | 湖北科技学院 | Synthetic method of natural product 6-HHC |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2670347A (en) * | 1952-01-08 | 1954-02-23 | American Cyanamid Co | Thiophosphoric acid derivatives and method of preparing the same |
| AT407833B (en) * | 1995-06-01 | 2001-06-25 | Nowicky Wassyl Dr | AGENTS FOR THE TREATMENT OF RADIATION DAMAGES |
-
2005
- 2005-09-09 WO PCT/EP2005/009699 patent/WO2006032380A1/en active Application Filing
- 2005-09-09 EP EP05782899A patent/EP1833839A1/en not_active Withdrawn
- 2005-09-09 CA CA002593202A patent/CA2593202A1/en not_active Abandoned
- 2005-09-19 AR ARP050103885A patent/AR050648A1/en unknown
- 2005-09-19 TW TW094132316A patent/TW200610763A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2593202A1 (en) | 2006-03-30 |
| WO2006032380A1 (en) | 2006-03-30 |
| EP1833839A1 (en) | 2007-09-19 |
| AR050648A1 (en) | 2006-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI106126B (en) | A process for the preparation of pharmaceutical 6-nitrogen substituted 4,5-epoxymorphinan derivatives | |
| TW200610763A (en) | Quaternary alkaloid derivatives | |
| EP2397476A3 (en) | Indole derivative having PGD2 receptor antagonist activity | |
| EP3137074B1 (en) | Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto | |
| AU683664B2 (en) | Antitussive | |
| CN106589055B (en) | Substituted cell acyl dipeptide compound and preparation method and application thereof | |
| CA2144770C (en) | Brain cell protective agent | |
| TNSN05230A1 (en) | Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments | |
| WO2011083304A1 (en) | Prodrugs of opioids and uses thereof | |
| HU228787B1 (en) | Sulfonamide-containing indole compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing the same | |
| CA2767987A1 (en) | Novel carbamate amino acid and peptide prodrugs of opioids and uses thereof | |
| JP2010508349A5 (en) | ||
| EP2125023A2 (en) | Soluble forms of inclusion complexes of histone deacetylase inhibitors and cyclodextrins, their preparation processes and uses in the pharmaceutical field | |
| US5216021A (en) | Analgesic method | |
| TW200603822A (en) | Quaternary chelidonine derivatives | |
| JO2648B1 (en) | Quaternary Chelidonine Derivatives | |
| US20230151121A1 (en) | Chitosan derivatives and methods for preparing the same | |
| JP2005533878A5 (en) | ||
| Rawat et al. | Synthesis and evaluation of mutual prodrugs of isoniazid, p-amino salicylic acid and ethambutol | |
| JP2012511580A5 (en) | ||
| WO2017158621A1 (en) | Trigonelline based compounds | |
| WO2013060023A1 (en) | Preparation method and intermediate of quinazoline derivative | |
| CN112334130A (en) | RSV replication inhibitors and uses thereof | |
| US20220041627A1 (en) | Prodrugs of anti-cancer and anti-autoimmune diseases therapeutic agents, and methods of making and use thereof | |
| RS40804A (en) | Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |